VELIN-PHARMA A/S — Credit Rating and Financial Key Figures
CVR number: 33026013
Kongevejen 66, Asminderød 3480 Fredensborg
Income statement (kDKK)
2019 | 2020 | 2021 | 2022 | 2023 | |
|---|---|---|---|---|---|
| Fiscal period length | 12 | 12 | 12 | 12 | 12 |
| Net sales | |||||
| Gross profit | 278.65 | 150.16 | 439.91 | 161.40 | -3.44 |
| EBIT | 278.65 | 150.16 | 439.91 | 161.40 | -3.44 |
| Other financial income | 4 020.03 | 7 488.19 | 3 561.25 | 8 618.47 | 17 704.05 |
| Other financial expenses | - 394.22 | -5.35 | -5.24 | - 943.08 | -1 427.25 |
| Net income from associates (fin.) | -12.76 | 0.41 | - 563.45 | 2.98 | |
| Pre-tax profit | 3 891.70 | 7 633.41 | 3 995.93 | 7 273.34 | 16 276.33 |
| Income taxes | - 407.89 | -1 679.34 | - 878.75 | -1 726.08 | -3 581.03 |
| Net earnings | 3 483.81 | 5 954.07 | 3 117.18 | 5 547.26 | 12 695.30 |
Assets (kDKK)
2019 | 2020 | 2021 | 2022 | 2023 | |
|---|---|---|---|---|---|
| Intangible assets total | |||||
| Tangible assets total | |||||
| Holdings in group member companies | 90.48 | ||||
| Participating interests | 1 865.45 | 1 865.45 | 1 865.45 | ||
| Investments total | 1 955.93 | 1 865.45 | 1 865.45 | ||
| Long term receivables total | |||||
| Finished products/goods | 215.50 | 262.72 | 204.90 | 28.46 | 470.86 |
| Advance payments | 95.16 | ||||
| Inventories total | 215.50 | 262.72 | 300.06 | 28.46 | 470.86 |
| Current trade debtors | 50.64 | 75.75 | 72.53 | 46.84 | 41.18 |
| Current other receivables | 3 490.87 | 3 891.49 | 2 848.72 | 4 023.33 | 2 163.48 |
| Short term receivables total | 3 541.51 | 3 967.24 | 2 921.25 | 4 070.18 | 2 204.66 |
| Other current investments | 16 080.23 | 23 195.96 | 26 115.23 | 33 939.39 | 49 427.42 |
| Cash and bank deposits | 921.73 | 590.75 | 874.05 | 410.45 | 873.14 |
| Cash and cash equivalents | 17 001.96 | 23 786.70 | 26 989.28 | 34 349.84 | 50 300.56 |
| Balance sheet total (assets) | 22 714.90 | 29 882.11 | 32 076.04 | 38 448.47 | 52 976.08 |
Equity and liabilities (kDKK)
2019 | 2020 | 2021 | 2022 | 2023 | |
|---|---|---|---|---|---|
| Share capital | 700.00 | 700.00 | 700.00 | 700.00 | 700.00 |
| Retained earnings | 17 986.41 | 21 470.22 | 27 424.29 | 30 541.47 | 36 088.73 |
| Profit of the financial year | 3 483.81 | 5 954.07 | 3 117.18 | 5 547.26 | 12 695.30 |
| Shareholders equity total | 22 170.22 | 28 124.29 | 31 241.47 | 36 788.73 | 49 484.02 |
| Non-current liabilities total | |||||
| Current trade creditors | 26.00 | 21.00 | 29.77 | 30.00 | |
| Current owed to group member | 133.85 | ||||
| Short-term deferred tax liabilities | 292.38 | 1 616.07 | 754.99 | 1 565.72 | 3 209.28 |
| Other non-interest bearing current liabilities | 118.46 | 115.75 | 58.59 | 64.24 | 252.78 |
| Current liabilities total | 544.68 | 1 757.82 | 834.58 | 1 659.74 | 3 492.06 |
| Balance sheet total (liabilities) | 22 714.90 | 29 882.11 | 32 076.04 | 38 448.47 | 52 976.08 |
Try the full version of our system for free
Create your own estimates for any company
Valuation analysis
See instructions
... and more!
No registration needed.